Skip Nav Destination
LETTER|
May 1, 1996
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT [letter; comment]
Blood (1996) 87 (9): 4011–4013.
Citation
S Slavin, E Naparstek, A Nagler, Y Kapelushnik, A Ackerstein, R Or; Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT [letter; comment]. Blood 1996; 87 (9): 4011–4013. doi: https://doi.org/10.1182/blood.V87.9.4011.bloodjournal8794011
Download citation file:
May 1 1996
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal